Paloma Partners Management CO Amneal Pharmaceuticals, Inc. Transaction History

Paloma Partners Management CO

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$3.95 - $5.42 $166,054 - $227,851	-42,039 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$3.54 - $5.27 $176,228 - $262,351	-49,782 Reduced 54.22%	42,039 $163,000
Q2 2020 Aug 14, 2020	BUY	$2.87 - $5.46 $263,526 - $501,342	91,821 New	91,821 $437,000
Q4 2019 Feb 14, 2020	SELL	$2.65 - $5.56 $29,680 - $62,271	-11,200 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$2.29 - $7.1 $25,648 - $79,520	11,200 New	11,200 $32,000
Q3 2018 Nov 14, 2018	SELL	$16.4 - $24.27 $6.73 Million - $9.96 Million	-410,305 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$13.95 - $20.2 $5.72 Million - $8.29 Million	410,305 New	410,305 $6.73 Million

185

141M

57K

49K

Ticker AMRX
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 151,408,992
Market Cap $1.26B
Description
Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...

Get notified when there are updates to the investment portfolio of Paloma Partners Management CO, based on Form 13F filings with the SEC.

Stay updated on Paloma Partners Management CO with notifications on news.